Knowledge, attitude, future expectations and perceived barriers of medical students and physicians regarding pharmacogenomics in Jordan

被引:14
作者
Alzoubi, Abdallah [1 ]
Kanaan, Hashem [2 ]
Alhazaimeh, Dua'a [2 ]
Gharaibeh, Salam [1 ]
Mukattash, Tareq L. [3 ]
Kheirallah, Khalid [2 ]
机构
[1] Jordan Univ Sci & Technol, Dept Pharmacol, Fac Med, POB 3030, Irbid 22110, Jordan
[2] Jordan Univ Sci & Technol, Fac Med, Dept Publ Hlth & Community Med, Irbid, Jordan
[3] Jordan Univ Sci & Technol, Fac Pharm, Dept Clin Pharm, Irbid, Jordan
关键词
ADVERSE DRUG-REACTIONS; CLINICAL VALIDITY; LESSONS;
D O I
10.1111/ijcp.13658
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Pharmacogenomics (PG) is a modern tool of personalising treatment protocols to improve the efficacy and safety of drug prescriptions. These benefits are offset by a slow uptake in clinical application due to a host of physician factors, patient factors and/or health system factors. Our study, thus, aimed to determine the knowledge, attitude, future expectations and perceived barriers of medical students and physicians in Jordan regarding PG testing. Methods A descriptive, cross-sectional study was conducted between February and August 2019. Physicians and senior medical students from academic and non-academic institutions in North Jordan (n = 424) were surveyed. A structured, self-administered questionnaire was designed and piloted for the purpose of the study. A scoring system for each dimension assessed was calculated and presented using means. Mean scores were compared by sociodemographic and professional variables. Results The response rate was 70.7%. The mean total PG knowledge score (+/- SD) was 5.42 (+/- 1.51) out of 10, with a significantly higher mean among respondents aged <30 years (5.54 +/- 1.43) compared with those >= 30 years old (5.21 +/- 1.62;P = .03). The mean total PG attitude score was 21.18 (+/- 2.58) out of 24, with significant differences by seniority levels evident (P = .03). The future expectations of PG among our sample were high, with a mean score of 10.44 (+/- 1.64) out of 12. The top three perceived barriers in applying PG were the high cost, lack of clinical guidelines, and limited knowledge and awareness. Conclusion Physicians and medical students in Jordan have low overall knowledge, albeit strongly positive attitude and future expectations towards PG, despite the perceived high cost and lack of clinical guidelines. Thus, we strongly recommend adopting a comprehensive educational strategy that aims to integrate PG concepts into medical curricula, and promote the culture of continuous medical education about PG among practitioners.
引用
收藏
页数:7
相关论文
共 43 条
[1]   Ethiopian health care professionals' knowledge, attitude, and interests toward pharmacogenomics [J].
Abdela, Ousman Abubeker ;
Bhagavathula, Akshaya Srikanth ;
Gebreyohannes, Eyob Alemayehu ;
Tegegn, Henok Getachew .
PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2017, 10 :279-285
[2]   Right Drug-Right Patient-Right Time: Personalized Medicine Coalition [J].
Abrahams, Edward .
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2008, 1 (01) :11-12
[3]   Knowledge, perceptions and confidence of physicians and pharmacists towards pharmacogenetics practice in Kuwait [J].
Albassam, Abdullah ;
Alshammari, Shahad ;
Ouda, Ghadeer ;
Koshy, Samuel ;
Awad, Abdelmoneim .
PLOS ONE, 2018, 13 (09)
[4]   An evaluation of the knowledge, opinions, expectations and concerns toward pharmacogenomics among Jordanian pharmacists [J].
AlEjielat, Rowan ;
Ejielat, Zeyad ;
Andrawes, Shireen ;
Mhaidat, Nizar M. .
PERSONALIZED MEDICINE, 2016, 13 (02) :143-154
[5]   Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes [J].
Altar, C. A. ;
Carhart, J. M. ;
Allen, J. D. ;
Hall-Flavin, D. K. ;
Dechairo, B. M. ;
Winner, J. G. .
PHARMACOGENOMICS JOURNAL, 2015, 15 (05) :443-451
[6]  
[Anonymous], 2006, Arab cultural awareness: 58 factsheets
[7]  
Arathy R, 2019, NAT J PHYSL PHARM PH, V9, P99
[8]   The clinical validity and utility of combinatorial pharmacogenomics: Enhancing patient outcomes [J].
Benitez, Joachim ;
Jablonski, Michael R. ;
Allen, Josiah D. ;
Winner, Joel G. .
APPLIED AND TRANSLATIONAL GENOMICS, 2015, 5 :47-49
[9]   Personalised medicine in Canada: a survey of adoption and practice in oncology, cardiology and family medicine [J].
Bonter, Katherine ;
Desjardins, Clarissa ;
Currier, Nathan ;
Pun, Jason ;
Ashbury, Fredrick D. .
BMJ OPEN, 2011, 1 (01)
[10]  
Carlberg C, 2012, PERS MED, V9, P147, DOI [10.2217/PME.11.96, 10.2217/pme.11.96]